LIBRARY CATALOGUE

The process of new drug discovery and development / (Record no. 3109)

MARC details
000 -LEADER
fixed length control field 05424cam a22005654a 4500
001 - CONTROL NUMBER
control field 14207733
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250823191811.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 051216s2006 nyua b 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2005036791
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101263798
Source DNLM
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0849327792
Qualifying information alk. paper
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780849327797
035 ## - SYSTEM CONTROL NUMBER
System control number 14207733
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)62736887
040 ## - CATALOGING SOURCE
Original cataloging agency DNLM/DLC
Transcribing agency DLC
Modifying agency NLM
-- BAKER
-- C#P
-- YDXCP
-- OCLCQ
-- MUQ
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.25.S55 2006
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number 2006 K-070
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 744
Item number P9645 2006
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615/.19
Edition information 22
245 04 - TITLE STATEMENT
Title The process of new drug discovery and development /
Statement of responsibility, etc. edited by Charles G. Smith, James T. O'Donnell.
250 ## - EDITION STATEMENT
Edition statement 2nd ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York :
Name of publisher, distributor, etc. Informa Healthcare,
Date of publication, distribution, etc. c2006.
300 ## - PHYSICAL DESCRIPTION
Extent 668 p. :
Other physical details ill. ;
Dimensions 27 cm.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Media type code n
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Carrier type code nc
Source rdacarrier
500 ## - GENERAL NOTE
General note Rev. ed. of: The process of new drug discovery and development / Charles G. Smith. c1992.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Overview of the current process of new drug discovery and development / Charles G. Smith and James T. O'Donnell -- Integrated drug product development: from lead candidate selection to life-cycle management / Madhu Pudipeddi, Abu T.M. Serajuddin, and Daniel Mufson -- The impact of combinatorial chemistry on drug discovery / Michael H. Rabinowitz and Nigel Shankley -- High-throughput screening: enabling and influencing the process of drug discovery / Carol Ann Homon and Richard M. Nelson -- Pharmacological and pharmaceutical profiling: new trends / Joanne Bowes ... [et al.] -- Cell-based analysis of drug response using moving optical gradient fields / Jeff M. Hall ... [et al.].
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Patient-derived primary cells in high-throughput differential antitumor screens: let the patients be the guide / Irwin A. Braude -- The evolving role of the caco-2 cell model to estimate intestinal absorption potential and elucidate transport mechanisms / Jibin Li and Ismael J. Hidalgo --
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note The promise of metabonomics in drug discovery / Harold J. Kwalwasser and Pauline Gee -- Pharmacogenetics and pharmacogenomics in drug development and regulatory decision-making: report of the first FDA-PWG-PhRMA-druSafe workshop / Lawrence J. Lesko ... [et al.] -- Drugs from molecular targets for CNS and neurodegenerative diseases / William T. Comer and Gönül Veliçelebi -- Safety pharmacology / Jean-Pierre Valentin and Tim G. Hammond -- Nonclinical drug safety assessment / Frederick E. Reno -- Preclinical genotoxicity testing: past, present and future / Richard H.C. San -- The need for animals in biomedical research / Charles G. Smith -- Defining the actual research approach to the new drug substance / Charles G. Smith -- Pharmacokinetics: pharmacodynamics in new drug development / Sarfaraz K. Niazi --
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Pharmaceutics and compounding issues in new drug development and marketing / Loyd V. Allen -- Late stage and process development activities / Charles G. Smith -- Contract research organizations: role and function in new drug development / F. Richard Nichol -- The front lines of clinical research: the industry / Lori Nesbitt -- Horizons for cancer chemotherapy (and nonchemotherapy) / Daniel D. Von Hoff -- Human immunodeficiency virus/acquired immune deficiency syndrome: clinical testing challenges / Vincent Idemyor -- Common technical document: the changing face of the new drug application / Justina A. Molzon -- Electronic publishing / Heather L. Wallace -- The important role of pharmacists in a complex risk-management system: managing the risks from medical product use by focusing on patient education, monitoring, and adverse event reporting / Justina A. Molzon -- Liability, litigation, and lessons in new drug development / James T. O'Donnell -- Problems in the nondrug marketplace / Stephen Barrett -- Patents and new product development in the pharmaceutical and biotechnology industries / Henry Grabowski --
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note The pharmaceutical revolution: drug discovery and development / John C. Somberg -- The discovery of Rituxan / Mitchell E. Reff -- Funding the birth of a drug: lessons from the sell side / Howard E. Greene -- Innovations for the drug development pathway: what is needed now / Janet Woodcock -- Managing R & D uncertainty and maximizing the commercial potential of pharmaceutical compounds using the dynamic modeling framework / Mark Paich ... [et al.].
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Research
-- History.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Design
-- History.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation, Preclinical.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Smith, Charles G.
Fuller form of name (Charles Giles)
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Donnell, James,
Titles and other words associated with a name Pharm. D.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Smith, Charles G.
Fuller form of name (Charles Giles)
Title of a work Process of new drug discovery and development.
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Table of contents
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/toc/ecip065/2005036791.html">http://www.loc.gov/catdir/toc/ecip065/2005036791.html</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified Publisher description
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/enhancements/fy0647/2005036791-d.html">http://www.loc.gov/catdir/enhancements/fy0647/2005036791-d.html</a>
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ecip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Suppress in OPAC No
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107005 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107006 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107007 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107008 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107009 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107010 07/10/2025 07/10/2025 Books
    Library of Congress Classification     Main Campus 3rd Floor Main Library General stacks 07/10/2025 Donation by KU   RM301.25.S55 2006 107011 07/10/2025 07/10/2025 Books